Barry 1 , L
The medication doesnt cause hair lossthe weight loss does: According to research published in PMC, the rapid and substantial weight reduction associated with semaglutide, tirzepatide, and similarGLP-1 medications can precipitate nutritional deficiencies and metabolic stress that trigger telogen effluviuma type of diffuse hair shedding resulting from disruption in the hair growth cycle
Pfeiffenberger, J., Weiss, K.-H
The first and only FDA-approved semaglutide pill for weight loss in adults with obesity or overweight with a weight-related condition
The Pharma Letter reports that obesity drug pipelines are increasingly focused on differentiation through combination pathways, enhanced tolerability and expanded delivery approaches as competition intensifies
PARP inhibitors as first-line therapy for men with mCRPC and variants in homologous recombination repair genes Evidence (talazoparib with enzalutamide): The combination of a PARP inhibitor, talazoparib, with enzalutamide was tested in the phase III, double-blind, randomized, multicohort TALAPRO-2 study (NCT03395197) as first-line therapy in men with mCRPC